Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection

OBJECTIVE: Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus confers a risk of significant coagulopathy, with the resulting development of venous thromboembolism (VTE), potentially contributing to the morbidity and mortality. The purpose of the present review was...

Descripción completa

Detalles Bibliográficos
Autores principales: Obi, Andrea T., Barnes, Geoffrey D., Napolitano, Lena M., Henke, Peter K., Wakefield, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the Society for Vascular Surgery. Published by Elsevier Inc. 2021
Materias:
COVID-19 and venous disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834652/
https://www.ncbi.nlm.nih.gov/pubmed/32916371
http://dx.doi.org/10.1016/j.jvsv.2020.08.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834652/
https://www.ncbi.nlm.nih.gov/pubmed/32916371
http://dx.doi.org/10.1016/j.jvsv.2020.08.030

Ejemplares similares